IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q2 2023 Holdings

Filed 2023-08-14 | 3 holdings | $165.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$74.9M2,346,93445.3%
Lyell Immunopharma IncCOM55083R104$64.1M20,162,33238.8%
Prime Medicine Inc(PRME)COM74168J101$26.3M1,792,21015.9%